antiinflammatory therapy (Kael-GemVax)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantiinflammatory therapy (Kael-GemVax)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCachexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKael-Gemvax Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKael-Gemvax Co Ltd
Active IndicationsN/A
Inactive IndicationsCachexia

Other Information

ATC CodeN/A
Related LinksN/A